Ideal Candidates for Factor VIII and Emicizumab for Hemophilia A

Robert Sidonio, Jr., MD, MSc, discusses treatment considerations and ideal candidates for factor VIII and emicizumab in patients with hemophilia A.

EP: 1.The Role of Prophylactic Therapy in Hemophilia A

EP: 2.Considerations for Prophylaxis in Patients With Hemophilia A

EP: 3.Selecting Prophylactic Therapy in Hemophilia A

Now Viewing

EP: 4.Ideal Candidates for Factor VIII and Emicizumab for Hemophilia A

EP: 5.Role of Specialty Pharmacies in the Management of Hemophilia A

EP: 6.Specialty Pharmacy Dispensing Process for Factor VIII and Emicizumab for Hemophilia A

EP: 7.Financial Challenges Associated With Prophylactic Treatment for Hemophilia A

EP: 8.Overcoming Barriers in Specialty Pharmacy for Treatment of Hemophilia A

EP: 9.Reflections on the Evolving Space of Prophylaxis in Hemophilia A

Related Videos

Related Content

Advertisement

March 2nd 2021

Digital Technology Has Changed the Landscape

Mike Hennessy Sr, Chairman

Related Content

Advertisement

March 2nd 2021

Digital Technology Has Changed the Landscape

Mike Hennessy Sr, Chairman